Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC 2025

WHF Stresses the Importance of Polypills in Global Fight Against CVD

Yael L. Maxwell

September 09, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

Michael O'Riordan

December 19, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Daily News

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

Caitlin E. Cox

August 24, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

Todd Neale

June 26, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

WHF Stresses the Importance of Polypills in Global Fight Against CVD

Heart Disease Treatment Costs $100 Billion per Year in the US

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

FDA Approves Triple Therapy Polypill for High Blood Pressure

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies

October 2023 News Roundup

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Aspirin as Secondary Prevention Still Subpar, Especially in Lower-Income Countries

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Method to Overcome CAC Score Variability Hones Risk Stratification

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

February 2023 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content